SecFilingDex
Form 3SMMTCIK 0001599298

Summit Therapeutics Inc.

Initial insider ownership (Form 3) filed .

Initial statement of beneficial ownership filed by a company's officers, directors, and 10%+ owners when they first become an insider.

Filing facts

Accession number
0001599298-24-000056
Filer
Summit Therapeutics Inc.
Ticker
SMMT
CIK
0001599298
Form type
Form 3
Form description
Initial insider ownership
Filed at
April 4, 2024
Period of report
2024-04-02
Filing size
3.8 KB
Last verified
August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.